AI assistant
Sending…
EXAGEN INC. — Director's Dealing 2024
Mar 4, 2024
33644_dirs_2024-03-04_80a302af-6955-49e6-be61-ec7a3801313b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2024-02-29
Reporting Person: ABALLI JOHN (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-29 | Common Stock | A | 9804 | $1.91 | Acquired | 600788 | Direct |
Footnotes
F1: Represents shares of common stock purchased through Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
More from EXAGEN INC.
Share Issue/Capital Change
2026
May 12
Interim / Quarterly Report
2026
May 11
Earnings Release
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Board/Management Information
2026
Apr 23
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11